524636
OXYGENTAPH
Start SIP
Invest Now
Start SIP in OXYGENTAPH
Oxygenta Pharmaceutical live price: ₹51.49. It opened at ₹51 vs previous close ₹49; intraday high/low: ₹52/₹49. The 50 & 200 DMA stand at ₹54.45/₹66.02.
Oxygenta Pharmaceutical Performance
- Low
- ₹49
- High
- ₹52
- 52 Week Low
- ₹46
- 52 Week High
- ₹134
- Open Price₹51
- Previous Close₹49
- Volume8,617
- 50 DMA₹54.45
- 100 DMA₹59.12
- 200 DMA₹66.02
Investment Returns
- Over 1 Month + 8.84%
- Over 3 Month -14.4%
- Over 6 Month -28.48%
- Over 1 Year -33.5%
Smart Investing Starts Here Start SIP with Oxygenta Pharmaceutical for Steady Growth!
Oxygenta Pharmaceutical Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -10.6
- PEG Ratio
- 0
- Market Cap Cr
- 190
- P/B Ratio
- -4.6
- Average True Range
- 3.78
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.55
- RSI
- 46.66
- MFI
- 56.58
Oxygenta Pharmaceutical Financials
Oxygenta Pharmaceutical Technicals
EMA & SMA
Current Price
₹51.49
+
2.04
(4.13%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹51.89
- 50 Day
- ₹54.45
- 100 Day
- ₹59.12
- 200 Day
- ₹66.02
Resistance and Support
50.77
- R3 54.25
- R2 52.92
- R1 52.10
- S1 49.95
- S2 48.62
- S3 47.80
Oxygenta Pharmaceutical Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-04 | Quarterly Results | |
| 2025-11-07 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Oxygenta Pharmaceutical F&O
About Oxygenta Pharmaceutical
- NSE Symbol
- OXYGENTAPH
- BSE Symbol
- 524636
- ISIN
- INE102E01018
Similar Stocks to Oxygenta Pharmaceutical
Oxygenta Pharmaceutical FAQs
Oxygenta Pharmaceutical share price is ₹51 As on 14 March, 2026 | 14:24
The Market Cap of Oxygenta Pharmaceutical is ₹190.4 Cr As on 14 March, 2026 | 14:24
The P/E ratio of Oxygenta Pharmaceutical is -10.6 As on 14 March, 2026 | 14:24
The PB ratio of Oxygenta Pharmaceutical is -4.6 As on 14 March, 2026 | 14:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.